87 related articles for article (PubMed ID: 22098838)
1. Molecular markers for incidence, prognosis, and response to therapy.
Tong BC; Harpole DH
Surg Oncol Clin N Am; 2012 Jan; 21(1):161-75. PubMed ID: 22098838
[TBL] [Abstract][Full Text] [Related]
2. Directed therapies in lung cancer: new hope?
Parente Lamelas I; Abal Arca J; Fírvida Pérez JL
Arch Bronconeumol; 2012 Oct; 48(10):367-71. PubMed ID: 22551924
[TBL] [Abstract][Full Text] [Related]
3. Combined targeted therapies in non-small cell lung cancer: a winner strategy?
Cascone T; Gridelli C; Ciardiello F
Curr Opin Oncol; 2007 Mar; 19(2):98-102. PubMed ID: 17272980
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNAs: possible prediction biomarkers for personalized therapy of non-small-cell lung carcinoma.
Gao W; Liu L; Lu X; Shu Y
Clin Lung Cancer; 2011 Jan; 12(1):14-7. PubMed ID: 21273174
[No Abstract] [Full Text] [Related]
5. Genetics and biomarkers in personalisation of lung cancer treatment.
Rosell R; Bivona TG; Karachaliou N
Lancet; 2013 Aug; 382(9893):720-31. PubMed ID: 23972815
[TBL] [Abstract][Full Text] [Related]
6. Individualized therapy in non-small-cell lung cancer: future versus current clinical practice.
Pérez-Soler R
Oncogene; 2009 Aug; 28 Suppl 1():S38-45. PubMed ID: 19680295
[TBL] [Abstract][Full Text] [Related]
7. Molecular prognostication of non-small cell lung cancer.
Tsao MS; Jablons DM
Semin Thorac Cardiovasc Surg; 2013; 25(1):4-7. PubMed ID: 23800523
[No Abstract] [Full Text] [Related]
8. Primary pulmonary lymphoepithelioma-like carcinoma: fifty-two patients with long-term follow-up.
Liang Y; Wang L; Zhu Y; Lin Y; Liu H; Rao H; Xu G; Rong T
Cancer; 2012 Oct; 118(19):4748-58. PubMed ID: 22359203
[TBL] [Abstract][Full Text] [Related]
9. Current treatment options for non-small-cell lung cancer.
Waxman ES
Oncology (Williston Park); 2012 Aug; 26(8 Suppl Nurse Ed):7-12. PubMed ID: 25375003
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic therapy in nonsmall cell lung cancer.
Gutierrez M; Giaccone G
Curr Opin Oncol; 2008 Mar; 20(2):176-82. PubMed ID: 18300767
[TBL] [Abstract][Full Text] [Related]
11. Targeted therapies for non-small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective.
Raben D; Helfrich B; Bunn PA
Int J Radiat Oncol Biol Phys; 2004; 59(2 Suppl):27-38. PubMed ID: 15142632
[TBL] [Abstract][Full Text] [Related]
12. [Angiogenesis and lung cancer].
Pérol M; Arpin D
Bull Cancer; 2007 Jul; 94 Spec No():S220-31. PubMed ID: 17846008
[TBL] [Abstract][Full Text] [Related]
13. Multitargeted receptor tyrosine kinase inhibition: an antiangiogenic strategy in non-small cell lung cancer.
Socinski MA
Cancer Treat Rev; 2011 Dec; 37(8):611-7. PubMed ID: 21641723
[TBL] [Abstract][Full Text] [Related]
14. New biological agents in the treatment of advanced non-small cell lung cancer.
Morrow PK; Kim ES
Semin Respir Crit Care Med; 2005 Jun; 26(3):323-32. PubMed ID: 16052434
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers, prediction, and prognosis in non-small-cell lung cancer: a platform for personalized treatment.
Sudhindra A; Ochoa R; Santos ES
Clin Lung Cancer; 2011 Nov; 12(6):360-8. PubMed ID: 21729648
[TBL] [Abstract][Full Text] [Related]
16. Pleural effusion in lung cancer: more questions than answers.
Froudarakis ME
Respiration; 2012; 83(5):367-76. PubMed ID: 22584211
[TBL] [Abstract][Full Text] [Related]
17. Expression, prognostic and predictive impact of VEGF and bFGF in non-small cell lung cancer.
Farhat FS; Tfayli A; Fakhruddin N; Mahfouz R; Otrock ZK; Alameddine RS; Awada AH; Shamseddine A
Crit Rev Oncol Hematol; 2012 Nov; 84(2):149-60. PubMed ID: 22494932
[TBL] [Abstract][Full Text] [Related]
18. The biology of non-small-cell lung cancer: identifying new targets for rational therapy.
Rosell R; Felip E; Garcia-Campelo R; Balaña C
Lung Cancer; 2004 Nov; 46(2):135-48. PubMed ID: 15474661
[TBL] [Abstract][Full Text] [Related]
19. Impact of serum hepatocyte growth factor on treatment response to epidermal growth factor receptor tyrosine kinase inhibitors in patients with non-small cell lung adenocarcinoma.
Kasahara K; Arao T; Sakai K; Matsumoto K; Sakai A; Kimura H; Sone T; Horiike A; Nishio M; Ohira T; Ikeda N; Yamanaka T; Saijo N; Nishio K
Clin Cancer Res; 2010 Sep; 16(18):4616-24. PubMed ID: 20679350
[TBL] [Abstract][Full Text] [Related]
20. Personalized peptide vaccination in patients with refractory non-small cell lung cancer.
Yoshiyama K; Terazaki Y; Matsueda S; Shichijo S; Noguchi M; Yamada A; Mine T; Ioji T; Itoh K; Shirouzu K; Sasada T; Takamori S
Int J Oncol; 2012 May; 40(5):1492-500. PubMed ID: 22307435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
